US Pharma MarketingFierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals
The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. At the American Society of Clinical Oncology (ASCO) meeting, Akeso took center stage with an ivonescimab presentation, and Fierce’s Angus Liu took a chance to dive into the bigger picture and symbolism behind the event. Elsewhere, calls in Washington to crack down on China biotech transactions are getting louder. Plus more. Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala…
The drumbeat of news regarding Asian pharma—and particularly China—continues to grow louder. At the American Society of Clinical Oncology (ASCO) meeting, Akeso took center stage with an ivonescimab presentation, and Fierce’s Angus Liu took a chance to dive into the bigger picture and symbolism behind the event. Elsewhere, calls in Washington to crack down on China biotech transactions are getting louder. Plus more.
Source: FiercePharma